TriSalus Life Sciences (TLSIW) Non Operating Income (2021 - 2026)
TriSalus Life Sciences (TLSIW) reported Non Operating Income of -$76000.0 for Q1 2026, up 69.72% on a YoY basis from -$44779.3 in Q1 2025, and down 7.04% quarter-over-quarter from -$71000.0 in Q4 2025.
TriSalus Life Sciences (TLSIW) Non Operating Income (2021 - 2026) Analysis & Trends
TriSalus Life Sciences has reported Non Operating Income for 6 years, with the latest figure at -$76000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income rose 69.72% year-over-year to -$76000.0; the trailing twelve-month figure through Mar 2026 stood at -$281000.0 (up 31.46% YoY), and the FY2025 full-year result was -$456000.0, down 46.15% from the prior year.
- Non Operating Income for Q1 2026 stood at -$76000.0, down from -$71000.0 in the prior quarter.
- The five-year high for Non Operating Income was $3.5 million in Q1 2022, with the low at -$349000.0 in Q4 2022.
- Historically, Non Operating Income has averaged $270955.6 across 5 years, with a median of -$44000.0 in 2024.
- Annual changes were most pronounced in 2022 — Non Operating Income soared 5575.36% — and 2024, when it tumbled 705.26%.
- TriSalus Life Sciences' Non Operating Income stood at -$349000.0 in 2022, then grew by 7.74% to -$322000.0 in 2023, then surged by 68.32% to -$102000.0 in 2024, then surged by 30.39% to -$71000.0 in 2025, then declined by 7.04% to -$76000.0 in 2026.
- The last three Non Operating Income figures came in at -$76000.0 (Q1 2026), -$71000.0 (Q4 2025), and -$94000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 159.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 121.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 61.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 71.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -55.03 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 14.20 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 36.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.80 Mn |
| 10 | TriSalus Life Sciences | - | - | 7.67 Mn | -76,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -76,000.00 |
| Dec 31, 2025 | -71,000.00 |
| Sep 30, 2025 | -94,000.00 |
| Jun 30, 2025 | -40,000.00 |
| Mar 31, 2025 | -251,000.00 |
| Dec 31, 2024 | -102,000.00 |
| Sep 30, 2024 | -13,000.00 |
| Jun 30, 2024 | -44,000.00 |
| Mar 31, 2024 | -153,000.00 |
| Dec 31, 2023 | -322,000.00 |
| Sep 30, 2023 | -13,000.00 |
| Jun 30, 2023 | -25,000.00 |
| Mar 31, 2023 | -19,000.00 |
| Dec 31, 2022 | -349,000.00 |
| Sep 30, 2022 | -31,000.00 |
| Jun 30, 2022 | 2.70 Mn |
| Mar 31, 2022 | 3.51 Mn |
| Dec 31, 2021 | 4.04 Mn |
| Sep 30, 2021 | 2.67 Mn |
| Jun 30, 2021 | 1.16 Mn |